SCHEMBL603689

SCHEMBL603689

COC(=O)O[C@@H]1CO[C@H]2[C@@H]1OC[C@@H]2OC

nearest known ligand 0.51

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
BCHE P06276 18/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11303679 1.00 BCHE (0.49) BCHE
SCHEMBL14007775 0.94 BCHE (0.53) BCHE
SCHEMBL603757 0.94 BCHE (0.53) BCHE
SCHEMBL13418768 0.85 BCHE (0.46) BCHE
SCHEMBL14007774 0.85 BCHE (0.46) BCHE
SCHEMBL602195 0.85 BCHE (0.49) BCHE
SCHEMBL13116062 0.84 BCHE (0.46) BCHE
SCHEMBL822521 0.82 BCHE (0.49) BCHE
SCHEMBL16261717 0.82 BCHE (0.49) BCHE
SCHEMBL822629 0.82 BCHE (0.49) BCHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2483276-B1 METHOD FOR PREPARING A DIALKYL CARBONATE OF DIANHYDROHEXITOL ROQUETTE FRERES (FR) 2016-11-02 EP disclosed
US-8399601-B2 Method for preparing a dialkyl carbonate of dianhydrohexitol ROQUETTE FRERES (FR) 2013-03-19 US disclosed
EP-2483276-A1 METHOD FOR PREPARING A DIALKYL CARBONATE OF DIANHYDROHEXITOL Roquette Freres (FR) 2012-08-08 EP disclosed
US-20120041169-A1 METHOD FOR PREPARING A DIALKYL CARBONATE OF DIANHYDROHEXITOL ROQUETTE FRERES (FR) 2012-02-16 US disclosed
WO-2011039483-A1 METHOD FOR PREPARING A DIALKYL CARBONATE OF DIANHYDROHEXITOL ROQUETTE FRERES (FR) 2011-04-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120041169-A1 METHOD FOR PREPARING A DIALKYL CARBONATE OF DIANHYDROHEXITOL TREH, DCXR, ADH1C BCHE 359/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.